Veracyte
VCYT
48 hedge funds and large institutions have $91.2M invested in Veracyte in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 14 closing their positions.
2% less capital invested
Capital invested by funds: $92.7M → $91.2M (-$1.5M)
9% less funds holding
Funds holding: 53 → 48 (-5)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Top Buyers
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$5.89M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.42M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.89M |
| 4 |
GP
Grow Partners
San Diego,
California
|
-$1.77M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.59M |
VCYT Hedge Fund Activity: Q4 2014 in Review
48 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2014, worth a combined $91.2M — down 1.6% from $92.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of VCYT and 10 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 13 added.
The largest buyer was Eventide Asset Management, adding an estimated $3.65M. The largest seller was Wells Fargo, cutting an estimated $5.89M.
- 48 institutional investors held Veracyte (VCYT) as of Q4 2014, down from 53 in Q3 2014.
- Funds reported $91.2M of Veracyte stock for Q4 2014, down 1.6% quarter-over-quarter.
- 10 funds opened new Veracyte positions in Q4 2014 and 14 closed out, a net change of -4 holders.
- The largest Veracyte buyer in Q4 2014 was Eventide Asset Management, an estimated $3.65M added.
- The largest Veracyte seller in Q4 2014 was Wells Fargo, an estimated $5.89M sold.
Based on aggregated 13F filings for Q4 2014.